(31 days)
Not Found
Not Found
No
The device is a calibrator for laboratory assays, which is a chemical reagent, not a software or hardware device that would typically incorporate AI/ML. The description focuses on its composition and intended use in calibrating other assays.
No
The device is a calibrator for assays, used for measurement and not for treating or diagnosing a condition.
No
This device is a calibrator for assays, not the diagnostic device itself. It is used to ensure the accuracy of diagnostic tests.
No
The device description explicitly states it is based on "lyophilised human serum," indicating a physical, biological component, not solely software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states it's for "calibration of Apolipoprotein A-1 and Apolipoprotein B assays." These assays are performed in vitro (outside the body) on biological samples (human serum).
- Device Description: It's "based on lyophilised human serum," which is a biological material used in in vitro testing.
- Function: Its function is to calibrate assays, which is a crucial step in ensuring the accuracy of in vitro diagnostic tests.
The definition of an IVD generally includes reagents, calibrators, control materials, kits, instruments, apparatus, equipment, or systems intended for use in the in vitro examination of specimens derived from the human body for the purpose of providing information for diagnostic, monitoring, or compatibility purposes. This device fits the description of a calibrator used in in vitro examination.
N/A
Intended Use / Indications for Use
The Randox Laboratories Limited Apolipoprotein Calibrator is based on lyophilised human serum and has been developed for use in the calibration of Apolipoprotein A-1 and Apolipoprotein B assays. The constituent concentrations of the Randox Laboratories Limited Apolipoprotein Calibrator are present at 1 level.
The Randox Labotatories Limited Apolipoprotein Calibrator should only be used by suitably qualified personnel, under appropriate laboratory conditions.
Product codes
JIX
Device Description
The Randox Laboratories Limited Apolipoprotein Calibrator is based on lyophilised human serum and has been developed for use in the calibration of Apolipoprotein A-1 and Apolipoprotein B assays.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
suitably qualified personnel, under appropriate laboratory conditions.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1150 Calibrator.
(a)
Identification. A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wing. The eagle faces to the right. Encircling the eagle is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.
Food and Drug Administration 098 Gaither Road Rockville MD 20850
Dr. Pauline Armstrong Randox Laboratories, Ltd. Biochemical Manufacturers Ardmore, Diamond Road Crumlin, CO. Antrim United Kingdom BT29 4QY
OCT 2 4 2002
Re: K023158
Trade/Device Name: APOLIPROTEIN CALIBRATOR Regulation Number: 21 CFR 862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Code: JIX Dated: September 16, 2002 Received: September 23, 2002
Dear Dr. Armstrong:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
Page 2 -
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and " additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrlvdsma/dsmamain.html".
Sincerely yours,
Steven Sutman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory-Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
510(k) Number (if known)
Ko23158 NOT KNOWN
Device Name:
APOLIPOPROTEIN CALIBRATOR
Indications For Use :
The Randox Laboratories Limited Apolipoprotein Calibrator is based on lyophilised human serum and has been developed for use in the calibration of Apolipoprotein A-1 and Apolipoprotein B assays. The constituent concentrations of the Randox Laboratories Limited Apolipoprotein Calibrator are present at 1 level.
The Randox Labotatories Limited Apolipoprotein Calibrator should only be used by suitably qualified personnel, under appropriate laboratory conditions.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use (Optional format 1-2-96)
Juan Cooper
(Division Sign-Off) Division of Clinical Labgratory 510(k) Number -